These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36385729)

  • 21. Physical activity support or weight loss counseling for nonalcoholic fatty liver disease?
    Montesi L; Caselli C; Centis E; Nuccitelli C; Moscatiello S; Suppini A; Marchesini G
    World J Gastroenterol; 2014 Aug; 20(29):10128-36. PubMed ID: 25110440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Barriers and Facilitators to Mediterranean Diet Adoption by Patients With Nonalcoholic Fatty Liver Disease in Northern Europe.
    Haigh L; Bremner S; Houghton D; Henderson E; Avery L; Hardy T; Hallsworth K; McPherson S; Anstee QM
    Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1364-1371.e3. PubMed ID: 30391437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Barriers and facilitators for treatment and control of high blood pressure among hypertensive patients in Kathmandu, Nepal: a qualitative study informed by COM-B model of behavior change.
    Bhandari B; Narasimhan P; Vaidya A; Subedi M; Jayasuriya R
    BMC Public Health; 2021 Aug; 21(1):1524. PubMed ID: 34372808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lifestyle Intervention Enabled by Mobile Technology on Weight Loss in Patients With Nonalcoholic Fatty Liver Disease: Randomized Controlled Trial.
    Lim SL; Johal J; Ong KW; Han CY; Chan YH; Lee YM; Loo WM
    JMIR Mhealth Uhealth; 2020 Apr; 8(4):e14802. PubMed ID: 32281943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An exploration of barriers and facilitators to implementing a nonalcoholic fatty liver disease pathway for people with type 2 diabetes in primary care.
    Gracen L; Hayward KL; Aikebuse M; Williams S; Russell A; O'Beirne J; Powell EE; Valery PC
    Diabet Med; 2022 Jun; 39(6):e14799. PubMed ID: 35100462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breaking Down Barriers to Physical Activity in Patients with Nonalcoholic Fatty Liver Disease.
    Stine JG; Soriano C; Schreibman I; Rivas G; Hummer B; Yoo E; Schmitz K; Sciamanna C
    Dig Dis Sci; 2021 Oct; 66(10):3604-3611. PubMed ID: 33098023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Barriers and enablers of weight management after breast cancer: a thematic analysis of free text survey responses using the COM-B model.
    Ee C; MacMillan F; Boyages J; McBride K
    BMC Public Health; 2022 Aug; 22(1):1587. PubMed ID: 35987564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Weight loss in nonalcoholic Fatty liver disease patients in an ambulatory care setting is largely unsuccessful but correlates with frequency of clinic visits.
    Dudekula A; Rachakonda V; Shaik B; Behari J
    PLoS One; 2014; 9(11):e111808. PubMed ID: 25375228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors influencing the prescribing behaviour of independent prescriber optometrists: a qualitative study using the Theoretical Domains Framework.
    Spillane D; Courtenay M; Chater A; Family H; Whitaker A; Acton JH
    Ophthalmic Physiol Opt; 2021 Mar; 41(2):301-315. PubMed ID: 33608897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What influences allied health clinician participation in research in the public hospital setting: a qualitative theory-informed approach.
    Wenke R; Noble C; Weir KA; Mickan S
    BMJ Open; 2020 Aug; 10(8):e036183. PubMed ID: 32819986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Barriers and facilitators to clinical behaviour change by primary care practitioners: a theory-informed systematic review of reviews using the Theoretical Domains Framework and Behaviour Change Wheel.
    Mather M; Pettigrew LM; Navaratnam S
    Syst Rev; 2022 Aug; 11(1):180. PubMed ID: 36042457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility and acceptability of an evidence-informed digital intervention to support self-management in people with non-alcoholic fatty liver disease: protocol for a non-randomised feasibility study (VITALISE).
    Avery L; Smith H; McPherson S; Hallsworth K
    Pilot Feasibility Stud; 2023 Apr; 9(1):62. PubMed ID: 37076916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Barriers and facilitators to the integration of mental health services into primary healthcare: a qualitative study among Ugandan primary care providers using the COM-B framework.
    Wakida EK; Obua C; Rukundo GZ; Maling S; Talib ZM; Okello ES
    BMC Health Serv Res; 2018 Nov; 18(1):890. PubMed ID: 30477492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding Primary Care Physician Perspectives on the Diagnosis and Management of Non-Alcoholic Fatty Liver Disease: A Qualitative Study.
    Heredia NI; John JC; Singh S; Hwang JP; Strong LL; Balakrishnan M; McNeill LH
    Inquiry; 2024; 61():469580241241272. PubMed ID: 38529894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An internet-based approach for lifestyle changes in patients with NAFLD: Two-year effects on weight loss and surrogate markers.
    Mazzotti A; Caletti MT; Brodosi L; Di Domizio S; Forchielli ML; Petta S; Bugianesi E; Bianchi G; Marchesini G
    J Hepatol; 2018 Nov; 69(5):1155-1163. PubMed ID: 30290973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.
    Katsagoni CN; Papatheodoridis GV; Ioannidou P; Deutsch M; Alexopoulou A; Papadopoulos N; Papageorgiou MV; Fragopoulou E; Kontogianni MD
    Br J Nutr; 2018 Jul; 120(2):164-175. PubMed ID: 29947322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Nonalcoholic Fatty Liver Disease and Weight Loss].
    Ping F; Li YX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Oct; 40(5):597-602. PubMed ID: 30404689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Barriers and Facilitators to Participating in an Exercise Referral Scheme among Women Living in a Low Socioeconomic Area in Australia: A Qualitative Investigation Using the COM-B and Theoretical Domains Framework.
    McKeon G; Mastrogiovanni C; Teychenne M; Rosenbaum S
    Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementation of evidence-based PCOS lifestyle management guidelines: Perceived barriers and facilitators by consumers using the Theoretical Domains Framework and COM-B Model.
    Pirotta S; Joham AJ; Moran LJ; Skouteris H; Lim SS
    Patient Educ Couns; 2021 Aug; 104(8):2080-2088. PubMed ID: 33581970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determinants of Physical Activity Engagement in Patients With Nonalcoholic Fatty Liver Disease: The Need for an Individualized Approach to Lifestyle Interventions.
    O'Gorman P; Monaghan A; McGrath M; Naimimohasses S; Gormley J; Norris S
    Phys Ther; 2021 Feb; 101(2):. PubMed ID: 33104787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.